AAAAAA
Results: 1-25/29
Authors:
Tomobe, M
Shimazui, T
Uchida, K
Akaza, H
Citation: M. Tomobe et al., AgNOR count in resting cells (resting NOR) is a new prognostic marker in invasive bladder tumor, ANAL CELL P, 22(4), 2001, pp. 193-199
Authors:
Onozawa, M
Fukuda, K
Watanabe, M
Ohtani, M
Akaza, H
Sugimura, T
Wakabayashi, K
Citation: M. Onozawa et al., Detection and cloning of a protein recognized by anti-human prostate-specific antigen (PSA) antibody in the rat ventral prostate, JPN J CANC, 92(8), 2001, pp. 863-868
Authors:
Otsuka, M
Yuzawa, K
Takada, Y
Taniguchi, H
Todoroki, K
Fukao, K
Koyama, A
Akaza, H
Citation: M. Otsuka et al., Long-term results of donor-specific blood transfusion with cyclosporine inliving related kidney transplantation, NEPHRON, 88(2), 2001, pp. 144-148
Authors:
Takahashi, T
Kushiro, A
Nomoto, K
Uchida, K
Morotomi, M
Yokokura, T
Akaza, H
Citation: T. Takahashi et al., Antitumor effects of the intravesical instillation of heat killed cells ofthe Lactobacillus casei strain Shirota on the murine orthotopic bladder tumor MBT-2, J UROL, 166(6), 2001, pp. 2506-2511
Authors:
Takimoto, Y
Shimazui, T
Akaza, H
Sato, N
Noguchi, M
Citation: Y. Takimoto et al., Genetic heterogeneity of surgically resected prostate carcinomas and theirbiopsy specimens is related to their histologic differentiation, CANCER, 91(2), 2001, pp. 362-370
Authors:
Akaza, H
Tsukamoto, S
Morita, T
Yamauchi, A
Onozawa, M
Shimazui, T
Ideyama, Y
Shirai, T
Citation: H. Akaza et al., Promoting effects of antiandrogenic agents on rat ventral prostate carcinogenesis induced by 3,2 '-dimethyl-4-aminobiphenyl (DMAB), PROSTATE C, 3(2), 2000, pp. 115-119
Authors:
Kawai, K
Tani, K
Asano, S
Akaza, H
Citation: K. Kawai et al., Ex vivo gene therapy using granulocyte-macrophage colony-stimulating factor-transduced tumor vaccines, MOL UROL, 4(2), 2000, pp. 43-46
Authors:
Homma-Takeda, S
Sasaki, A
Kikushima, M
Kumagai, Y
Uchida, K
Kawai, K
Akaza, H
Shimojo, N
Citation: S. Homma-takeda et al., Enzyme activity and protein content of superoxide dismutase isozymes in human renal cell carcinoma, RES COM M P, 108(1-2), 2000, pp. 49-55
High-dose chemotherapy with peripheral blood stem cell transplantation foradvanced testicular cancer
Authors:
Miyazaki, J
Miyanaga, N
Kawai, K
Shimazui, T
Takeshima, H
Akaza, H
Citation: J. Miyazaki et al., High-dose chemotherapy with peripheral blood stem cell transplantation foradvanced testicular cancer, INT J UROL, 7(7), 2000, pp. 258-262
Authors:
Miyanaga, N
Akaza, H
Okumura, T
Sekido, N
Kawai, K
Shimazui, T
Kikuchi, K
Uchida, K
Takeshima, H
Ohara, K
Akine, Y
Itai, Y
Citation: N. Miyanaga et al., A bladder preservation regimen using intra-arterial chemotherapy and radiotherapy for invasive bladder cancer: A prospective study, INT J UROL, 7(2), 2000, pp. 41-48
Authors:
Akaza, H
Homma, Y
Okada, K
Yokoyama, M
Moriyama, N
Usami, M
Hirao, Y
Tsushima, T
Ohashi, Y
Aso, Y
Citation: H. Akaza et al., Early results of LH-RH agonist treatment with or without chlormadinone acetate for hormone therapy of naive localized or locally advanced prostate cancer: A prospective and randomized study, JPN J CLIN, 30(3), 2000, pp. 131-136
Authors:
Uchida, K
Takeshima, H
Akaza, H
Ono, Y
Citation: K. Uchida et al., Screening for prostate cancer using prostate-specific antigen alone as a first-line checkup parameter: Results of the health checkup system, JPN J CLIN, 30(2), 2000, pp. 95-100
Authors:
Akaza, H
Citation: H. Akaza, Urologic malignancies: Introduction, WORLD J SUR, 24(10), 2000, pp. 1153-1153
Authors:
Kawai, K
Hattori, K
Akaza, H
Citation: K. Kawai et al., Tissue-engineered artificial urothelium, WORLD J SUR, 24(10), 2000, pp. 1160-1162
Authors:
Tani, K
Nakazaki, Y
Hase, H
Takahashi, K
Azuma, M
Ohata, J
Kitamura, R
Komine, F
Oiwa, M
Masunaga, A
Maekawa, T
Satoh, N
Adachi, D
Soda, Y
Machida, U
Endo, M
Yamazaki, T
Watari, K
Tojo, A
Yamashita, N
Tomikawa, S
Eriguchi, M
Hamada, H
Wakumoto, Y
Hanazawa, K
Okumura, K
Fujime, M
Shuin, T
Kawai, K
Akaza, H
Clift, S
Ando, D
Sherwin, S
Mulligan, R
Asano, S
Citation: K. Tani et al., Progress reports on immune gene therapy for stage IV renal cell cancer using lethally irradiated granulocyte-macrophage colony-stimulating factor-transduced autologous renal cancer cells, CANC CHEMOT, 46, 2000, pp. S73-S76
Authors:
Shimazui, T
Oosterwijk-Wakka, J
Akaza, H
Bringuier, PP
Ruijter, E
Debruyne, FMJ
Schalken, JA
Oosterwijk, E
Citation: T. Shimazui et al., Alterations in expression of cadherin-6 and E-cadherin during kidney development and in renal cell carcinoma, EUR UROL, 38(3), 2000, pp. 331-338
Authors:
Ota, T
Asamoto, M
Toriyama-Baba, H
Yamamoto, F
Matsuoka, Y
Ochiya, T
Sekiya, T
Terada, M
Akaza, H
Tsuda, H
Citation: T. Ota et al., Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladdercarcinogenesis, CARCINOGENE, 21(7), 2000, pp. 1391-1396
Authors:
Tomobe, M
Shimazui, T
Uchida, K
Hinotsu, S
Akaza, H
Citation: M. Tomobe et al., Re: Argyrophilic nucleolar organizer region in proliferating cell has a predictive value for local recurrence in superficial bladder tumor - Reply, J UROL, 163(5), 2000, pp. 1525-1525
Authors:
Homma, Y
Akaza, H
Okada, K
Yokoyama, M
Moriyama, N
Usami, M
Hirao, Y
Tsushima, T
Sakamoto, A
Ohashi, Y
Aso, Y
Citation: Y. Homma et al., Early results of radical prostatectomy and adjuvant endocrine therapy for prostate cancer with or without preoperative androgen deprivation, INT J UROL, 6(5), 1999, pp. 229-237
Authors:
Miyanaga, N
Akaza, H
Tsukamoto, T
Ishikawa, S
Noguchi, R
Ohtani, M
Kawabe, K
Kubota, Y
Fujita, K
Obata, K
Hirao, Y
Kotake, T
Ohmori, H
Kumazawa, J
Koiso, K
Citation: N. Miyanaga et al., Urinary nuclear matrix protein 22 as a new marker for the screening of urothelial cancer in patients with microscopic hematuria, INT J UROL, 6(4), 1999, pp. 173-177
Authors:
Ota, T
Kawai, K
Hattori, K
Uchida, K
Akaza, H
Harada, M
Citation: T. Ota et al., Hamartoma of the urinary bladder, INT J UROL, 6(4), 1999, pp. 211-214
Authors:
Kotake, T
Usami, M
Miki, T
Togashi, M
Akaza, H
Kubota, Y
Matsumura, Y
Citation: T. Kotake et al., Effect of recombinant human granulocyte colony stimulating factor (lenograstim) on chemotherapy induced neutropenia in patients with urothelial cancer, INT J UROL, 6(2), 1999, pp. 61-67
Authors:
Onozawa, M
Kawamori, T
Baba, M
Fukuda, K
Toda, T
Sato, H
Ohtani, M
Akaza, H
Sugimura, T
Wakabayashi, K
Citation: M. Onozawa et al., Effects of a soybean isoflavone mixture on carcinogenesis in prostate and seminal vesicles of F344 rats, JPN J CANC, 90(4), 1999, pp. 393-398
Authors:
Uchida, K
Akaza, H
Hattori, K
Noguchi, R
Kondo, F
Ishikawa, S
Ohtani, M
Hinotsu, S
Koiso, K
Citation: K. Uchida et al., Antiemetic efficacy of granisetron: a randomized crossover study in patients receiving cisplatin-containing intraarterial chemotherapy, JPN J CLIN, 29(2), 1999, pp. 87-91
Authors:
Kotake, T
Usami, M
Akaza, H
Koiso, K
Homma, Y
Kawabe, K
Aso, Y
Orikasa, S
Shimazaki, J
Isaka, S
Yoshida, O
Hirao, Y
Okajima, E
Naito, S
Kumazawa, J
Kanetake, H
Saito, Y
Ohi, Y
Ohashi, Y
Citation: T. Kotake et al., Goserelin acetate with or without antiandrogen or estrogen in the treatment of patients with advanced prostate cancer: a multicenter, randomized, controlled trial in Japan, JPN J CLIN, 29(11), 1999, pp. 562-570